Synthesis of imidazo[1,2-a]pyridines as antiviral agents. 1998

A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200 Tours, France.

The synthesis of original imidazo[1,2-a]pyridines bearing a thioether side chain at the 3 position and their antiviral activity are reported. From the synthesized compounds, 4, 15, and 21 were highly active against human cytomegalovirus with a therapeutic index superior to 150. These compounds also showed pronounced activity against varicella-zoster virus. Their structure-activity relationship is discussed.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
July 2004, Journal of medicinal chemistry,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
March 1992, Chemical & pharmaceutical bulletin,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
October 2021, Archiv der Pharmazie,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
November 2022, Bioorganic chemistry,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
September 1989, Journal of medicinal chemistry,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
June 2003, The Journal of organic chemistry,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
January 2015, Chemical communications (Cambridge, England),
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
January 2008, Bioorganic & medicinal chemistry,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
May 2023, Organic letters,
A Gueiffier, and S Mavel, and M Lhassani, and A Elhakmaoui, and R Snoeck, and G Andrei, and O Chavignon, and J C Teulade, and M Witvrouw, and J Balzarini, and E De Clercq, and J P Chapat
October 1987, Journal of medicinal chemistry,
Copied contents to your clipboard!